Aptar Pharma announced a collaboration with Aceso Therapeutics to advance the development of ACT-101, an antisense oligonucleotide candidate designed to target cystic fibrosis.
Public source
Publisher name
Public post
Aptar Pharma is pleased to announce a collaboration with Aceso Therapeutics, a biotech developing novel therapies for cystic fibrosis, to advance the development of ACT-…
Company
Aptar
- Industry
- Packaging and Containers Manufacturing
- Location
- US
- Company size
- 5,001–10,000 employees
About Aptar
Every day, Aptar creates “a-ha moments” for its customers and their consumers and patients by continually bringing innovations to market that convert non-dispensing packaging into breakthrough product-dispensing systems, including those that give people more effective ways to put on their favorite fragrance, kids the opportunity to pour ketchup without making a mess and patients connected technologies that help them more easily adhere to treatment. Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com. All of Aptar's current job openings are found at jobs.aptar.com. Job applicants should be aware of recruiting scams on the Internet and social media platforms. The scammers frequently use a company’s logo and photos or the names of its executives to give the appearance of legitimacy. The fraud targets job seekers and uses false and fraudulent offers of employment with legitimate employers, like Aptar, to steal from the victims. No applicant for employment with Aptar is ever required to pay any money as part of the job application or hiring process. In addition, Aptar’s recruiting staff sends email communications to job applicants from email addresses with the “@aptar.com” domain name only. To read more about recruiting fraud or to report an incident please see Aptar's Recruiting Fraud Statement. https://aptar.com/careers/recruiting-fraud-statement/
See moreLatest activity
Latest activity from Aptar
17 signals
Presence & Recognition
Aptar received the German Packaging Award 2026 in the Sustainability category for its joint innovation with Werner & Mertz.
Presence & Recognition
Aptar Pharma showcased capabilities across drug delivery at Nordic Life Science Days in Stockholm, featuring Injectables colleagues Aurélien Barré and Xavier Thiry.
Customers
Aptar Pharma's specialist inhalation development services business, Nanopharm Ltd, will lead formulation development and device assessment activities to support Aceso's clinical development roadmap for ACT-101.
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
Aceso Therapeutics
Aceso Therapeutics is collaborating with Nanopharm, part of Aptar Pharma, leveraging inhalation science and formulation development expertise to accelerate the development of ACT-101.
Partnerships
Intellitech, Inc.
Intellitech, Inc. and Andelyn Biosciences announced that Andelyn will support the transition of Genprex’s AAV-based diabetes gene-therapy program toward IND-enabling studies and clinical manufacturing.
Partnerships
ThermoSafe
ThermoSafe is a NASP member to collaborate with specialty pharmacy leaders to better understand evolving last-mile challenges and share expertise to protect medication integrity, advance patient safety, and improve the delivery experience.
Partnerships
Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing partnered with LTS Lohmann Therapie-Systeme AG to provide clients with a comprehensive solution for pre-filled containers and the Sorrel on-body delivery devices.
Partnerships
Lifecore Biomedical